- Home
- SNBR vs KMDA Comparison
SNBR vs KMDA Comparison
Compare SNBR & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- KMDA
- Stock Information
- Founded
- SNBR 1987
- KMDA 1990
- Country
- SNBR United States
- KMDA Israel
- Employees
- SNBR N/A
- KMDA N/A
- Industry
- SNBR Home Furnishings
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- KMDA Health Care
- Exchange
- SNBR Nasdaq
- KMDA Nasdaq
- Market Cap
- SNBR 399.8M
- KMDA 399.7M
- IPO Year
- SNBR 1998
- KMDA N/A
- Fundamental
- Price
- SNBR $6.86
- KMDA $7.76
- Analyst Decision
- SNBR Hold
- KMDA Strong Buy
- Analyst Count
- SNBR 2
- KMDA 3
- Target Price
- SNBR $9.00
- KMDA $14.67
- AVG Volume (30 Days)
- SNBR 541.3K
- KMDA 85.3K
- Earning Date
- SNBR 07-30-2025
- KMDA 08-13-2025
- Dividend Yield
- SNBR N/A
- KMDA 2.57%
- EPS Growth
- SNBR N/A
- KMDA 31.21
- EPS
- SNBR N/A
- KMDA 0.28
- Revenue
- SNBR $1,605,108,000.00
- KMDA $167,235,000.00
- Revenue This Year
- SNBR N/A
- KMDA $14.51
- Revenue Next Year
- SNBR $4.27
- KMDA $9.31
- P/E Ratio
- SNBR N/A
- KMDA $27.88
- Revenue Growth
- SNBR N/A
- KMDA 11.83
- 52 Week Low
- SNBR $4.48
- KMDA $4.83
- 52 Week High
- SNBR $20.75
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- SNBR 37.59
- KMDA 74.94
- Support Level
- SNBR $6.36
- KMDA $7.13
- Resistance Level
- SNBR $7.32
- KMDA $8.20
- Average True Range (ATR)
- SNBR 0.61
- KMDA 0.20
- MACD
- SNBR -0.22
- KMDA 0.10
- Stochastic Oscillator
- SNBR 11.59
- KMDA 79.31
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.